Medical devices for shunts, occluders, fenestrations, and related systems and methods
By designing implantable medical equipment, the frame parts and catheter parts cross the diaphragm to regulate the blood pressure between the left and right atriums of the heart, the problem of insufficient blood pressure regulation in the prior art is solved, and the efficient adaptability and stability of the equipment is achieved sex, reducing the risk of thrombosis.
Patent Information
- Application Number
- CN201980047988.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2018-07-18
- Filing Date
- 2019-07-17
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2039-07-17
AI Technical Summary
The existing treatment methods for heart failure are difficult to effectively regulate blood pressure between the left and right sides of the heart, and there is a problem of insufficient equipment adaptability.
An implantable medical device is designed, including a frame component and a catheter portion configured to conform to the patient's anatomy, spanning the cardiac diaphragm through the catheter portion, allowing fluid to flow through, and expanding the diaphragm through the tension of the frame member to provide a fluid flow path, Also equipped with sensors and drug coatings to regulate hemodynamics and tissue responses.
It realizes effective regulation of blood pressure between the left and right atriums of the heart, enhances the decompression and shunt effect of blood flow, improves the adaptability and stability of the equipment, reduces the chance of thrombosis, and promotes histocompatibility.
Smart Images

Figure CN112423673B_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims the benefit of Provisional Patent Application No. 62 / 699,815, filed on July 18, 2018, which is incorporated herein by reference in its entirety for all purposes. Technical Field
[0003] The present disclosure relates generally to implantable medical devices, and more particularly to implantable medical devices and related systems and methods for diverting and / or occluding body fluids or body structures. Background Art
[0004] Heart failure and heart disease affect millions of people worldwide. Heart failure includes failure of the left side of the heart, the right side of the heart, or both sides. Heart diseases that can lead to heart failure include high blood pressure, pulmonary hypertension, and congenital defects of the heart. The evolving nature of heart failure represents a significant challenge to treatment approaches. Therefore, new and adaptable methods and devices for treating heart failure are needed. Summary of the invention
[0005] In one example (“Example 1”), an implantable medical device includes a first frame component configured to conform to the anatomy of a patient; a second frame component configured to conform to the anatomy of the patient, wherein the first frame component and the second frame component are discrete and separate from each other; and a conduit portion disposed between the first frame component and the second frame component, the conduit portion including a membrane connecting the first frame component and the second frame component.
[0006] In another example ("Example 2") further to the apparatus of Example 1, at least a portion of the conduit portion is not radially supported within the conduit portion by the first frame member and the second frame member.
[0007] In another example ("Example 3") further to the apparatus of Example 2, the first frame member and the second frame member are configured to facilitate deployment of the catheter portion and maintain a lumen through the catheter portion.
[0008] In another example ("Example 4") further to the apparatus of any of Examples 1 to 3, the conduit portion is devoid of a frame member.
[0009] In another example ("Example 5") further to the apparatus of any one of Examples 1 to 4, the first frame component includes a first group of elongated elements and the second frame component includes a second group of elongated elements, and the first group of elongated elements and the second group of elongated elements are not adjacent to (not contiguous with) each other.
[0010] In another further example ("Example 6") of the apparatus relative to Example 5, the first group of elongated elements comprises a first plurality of support struts, and wherein the second group of elongated elements comprises a second plurality of support struts, the first and second plurality of support struts forming a support structure within each elongated element.
[0011] In another example ("Example 7") further to the apparatus of Example 6, the first group of elongated elements forms a plurality of first lobes.
[0012] In another example ("Example 8") further to the apparatus of Example 6, the first set of elongated elements forms a star shape.
[0013] In another further example ("Example 9") relative to any one of Examples 5 to 8, the first frame member forms the first side and the second frame member forms the second side, and wherein at least one of the first group of slender elements is disposed within the first frame member without penetrating the second side, and the second group of slender elements is disposed within the second frame member without penetrating the first side.
[0014] In another example ("Example 10") further to the apparatus of Example 9, at least one of the first group of elongated elements and the second group of elongated elements extends within the conduit portion.
[0015] In another example ("Example 11") further to the apparatus of any of Examples 1 to 10, the film extends to at least partially cover portions of one or both of the first frame member and the second frame member.
[0016] In another example ("Example 12") further to the apparatus of Example 11, the membrane is configured to promote tissue ingrowth to cover at least a portion of one or both of the first frame member and the second frame member.
[0017] In another example ("Example 13") further to the apparatus of any one of Examples 1 to 12, the apparatus further includes a first membrane film disposed on the first frame member and a second membrane film disposed on the second frame member.
[0018] In another example ("Example 14") further to the apparatus of any of Examples 1 to 3, the membrane separates the first frame member and the second frame member by a gap of 0 to 15 mm.
[0019] In one example (“Example 15”), an implantable medical device for regulating blood pressure between the left atrium and the right atrium of a heart includes: a catheter portion configured to span a septum of the heart and to allow fluid to flow therethrough; and a frame portion comprising a first group of elongated elements disposed on a first side of the catheter portion and a second group of elongated elements disposed on a second side of the catheter portion, wherein the first group of elongated elements and the second group of elongated elements are not adjacent to (not contiguous with) each other.
[0020] In another further example ("Example 16") of the device relative to Example 15, the frame portion forms a first side including a first group of slender elements and a second side including a second group of slender elements, and wherein the first group of slender elements are arranged in the first side and the conduit portion, and the second group of slender elements are arranged in the second side and the conduit portion.
[0021] In another further example ("Example 17") of the apparatus of any one of Examples 15 to 16, a first group of elongated members and a second group of elongated members extend radially outward from the conduit portion to form a first angle and a second angle, and wherein the first angle and the second angle are angles of approximately 90° relative to the conduit portion.
[0022] In another further example ("Example 18") of the device of any one of Examples 15 to 17, the device also includes a sensor arranged with the catheter portion or the frame portion, and the sensor is constructed to sense at least one of physiological properties, hemodynamics, biomarkers, sound, pressure, and electrolytes.
[0023] In another further example ("Example 19") relative to any one of Examples 15 to 18, the device also includes at least one of a heparin coating for promoting anti-thrombotic properties of the device and patency of the device and a paclitaxel coating for modulating (regulating) tissue / cellular responses.
[0024] In one example ("Example 20"), a method for regulating blood pressure between the left atrium and the right atrium of the heart includes delivering an implantable medical device to a desired treatment location in a patient's body, the implantable medical device comprising: a catheter portion, the catheter portion being configured to span a septum of the heart and being configured to allow fluid to flow therethrough; a frame portion, the frame portion comprising a first group of elongated elements disposed on a first side of the catheter portion and a second group of elongated elements disposed on a second side of the catheter portion, wherein the first group of elongated elements and the second group of elongated elements are not adjacent to (not contiguous with) each other; positioning the device so that the catheter portion spans the septum between the left atrium and the right atrium of the heart; and unfolding the first frame portion and the second frame portion so that the catheter portion opens a desired amount to provide a fluid flow path between the left atrium and the right atrium.
[0025] In another example ("Example 21") further than the method of Example 20, the method also includes adjusting tension on the device to adjust a diameter of the catheter portion and a fluid flow rate therethrough.
[0026] According to one example ("Example 22"), an implantable medical device includes a first frame member; a second frame member, wherein the first frame member and the second frame member are discrete and separated from each other; and a catheter portion disposed between the first frame member and the second frame member, the catheter portion including a membrane connecting the first frame member and the second frame member, the membrane being configured to expand in response to tension in the catheter portion applied by expansion of the first frame member and the second frame member.
[0027] In another further example ("Example 23") of the apparatus relative to Example 22, the catheter portion is constructed to span a septum between the left atrium and the right atrium of the patient, and the catheter portion is constructed to expand the septum in response to tension applied in the catheter portion by expansion of the first frame portion and the second frame portion.
[0028] In another example ("Example 24") further to the apparatus of Example 23, the catheter portion is configured to maintain an expanded diameter of the septum.
[0029] In another further example ("Example 25") of the device relative to Example 22, a first frame member forms a first side, a second frame member forms a second side, and wherein at least one of the first group of slender elements is disposed within the first frame member without penetrating the second side, and wherein the second group of slender elements is disposed within the second frame member without penetrating the first side.
[0030] In another example ("Example 26") further to the apparatus of Example 25, at least one set of the elongated elements of the first set and the second set of elongated elements extends within the conduit portion.
[0031] The foregoing examples are merely, and should not be construed as limiting or otherwise narrowing the scope of any inventive concept provided by the present disclosure. Although a number of examples are disclosed, other examples will become apparent to those skilled in the art from the following detailed description, which illustrates and describes illustrative examples of the present invention. Therefore, the drawings and detailed description should be considered to be illustrative in nature and not restrictive in nature. BRIEF DESCRIPTION OF THE DRAWINGS
[0032] The accompanying drawings are used to provide a further understanding of the present disclosure, and are incorporated in and constitute a part of this specification, illustrate embodiments, and together with the description serve to explain the principles of the present disclosure.
[0033] Figure 1is an example implantable medical device for regulating blood pressure according to an embodiment.
[0034] Figure 2 is an example implantable medical device for regulating blood pressure according to an embodiment.
[0035] Figure 3A is a perspective view of another example implantable medical device for regulating blood pressure according to an embodiment.
[0036] Figure 3B According to an embodiment, Figure 3A A side view of an implantable medical device for regulating blood pressure is shown in FIG.
[0037] Figure 4 is an example implantable medical device according to an embodiment.
[0038] Figure 5A is a first perspective view of another example implantable medical device for regulating blood pressure according to an embodiment.
[0039] Figure 5B According to an embodiment, Figure 5A A second perspective view of an implantable medical device for regulating blood pressure is shown in FIG.
[0040] Figure 5C is a third perspective view of an implantable medical device for regulating blood pressure according to an embodiment.
[0041] Figure 6 is an example stent pattern of a deployment system and an implantable medical device for regulating blood pressure according to an embodiment.
[0042] Figure 7 is another example stent type of a deployment system and an implantable medical device for regulating blood pressure according to an embodiment.
[0043] Figures 8A-8B is an example implantable medical device disposed on a mandrel according to an embodiment.
[0044] Figure 8C-8D FIG. 1 is a diagram showing a device implanted in a patient according to an embodiment. Fig. 8A and 8B The example shown is an implantable medical device.
[0045] Fig. 9 is another example implantable medical device according to an embodiment.
[0046] Fig.10 is another example implantable medical device according to an embodiment. DETAILED DESCRIPTION
[0047] Definitions and terminology
[0048] This disclosure is not intended to be read in a limiting manner. For example, the terms used in this application should be read broadly in the context of the meanings that those skilled in the art would attribute to such terms.
[0049] With respect to imprecise terms, the terms "about" and "approximately" are used interchangeably to refer to a measurement value that includes the measurement value and also includes any measurement value that is reasonably close to the measurement value. As understood and easily determined by a person of ordinary skill in the relevant art, a measurement value that is reasonably close to the measurement value deviates from the measurement value by a relatively small amount. Such deviations may be attributed to, for example, measurement errors, differences in the measurement values and / or calibration of manufacturing equipment, human errors in reading and / or setting the measurement values, fine-tuning to optimize performance and / or structural parameters in view of differences in the measurement values associated with other components, specific implementation scenarios, imprecise adjustment and / or manipulation of the object by a person or machine, and / or the like. If it is determined that a person of ordinary skill in the relevant art would not easily determine the value of such a reasonable small difference, the terms "about" and "approximately" may be understood to be plus or minus 10% of the value.
[0050] Description of various embodiments
[0051] Those skilled in the art will readily appreciate that various aspects of the present invention may be implemented by any number of methods and devices configured to perform the intended functions. It should also be noted that the drawings referenced herein are not necessarily drawn to scale, but may be exaggerated to illustrate various aspects of the present disclosure, and in this regard, the drawings should not be construed as limiting.
[0052] Various aspects of the present disclosure are directed to implantable medical devices, such as devices for shunting and / or occluding body fluids or body structures. In some cases, various aspects of the present disclosure relate to methods and devices for treating heart failure by creating (forming) a pressure-reducing shunt to reduce elevated blood pressure in the ventricles. In addition, some embodiments relate to methods and devices for customizing, adjusting, or manipulating blood flow (blood flow) through a shunt to enhance the therapeutic effect of a pressure-reducing shunt.
[0053] Figure 1is an example implantable medical device for regulating blood pressure according to one embodiment. Implantable medical device 100 is shown implanted in a patient's heart H. Device 100 is shown disposed between the patient's left atrium and right atrium. In some cases, device 100 can be used to regulate blood flow within heart H, for example, blood flow between the left atrium LA and the right atrium RA. As shown, device 100 generally includes a first frame member 110 disposed on a first side of a septum (e.g., within the right atrium RA), a second frame member 120 disposed on a second side of the septum (e.g., within the left atrium LA), and a catheter portion 130 extending through the septum. A needle can be used to create an opening in the septum.
[0054] The sheath 140 and restraint and / or release lines (not shown) can be used to facilitate deployment of the device 100. For example, a first side of the device 100 including the first frame member 110 can be released after the sheath 140 is advanced through the septum and reaches the RA, and a second side 120 including the second frame member 120 can be released on the LA side of the septum. The catheter portion 130 (e.g., Figure 2 The frame assemblies 110, 120 and the catheter portion 130 may be compressed within the sheath 140 during delivery of the device 100 to a desired treatment area within a patient, and subsequently expanded during deployment of the device 100.
[0055] Figure 2 is an example implantable medical device for regulating blood pressure according to an embodiment. As shown, the device 100 includes a first frame member 110 and a second frame member 120. The first frame member 110 can be configured to conform to the patient's anatomy (i.e., a first side of a diaphragm, for example). The second frame member 120 can be configured to conform to the patient's anatomy (i.e., a second side of a diaphragm).
[0056] In some cases, the first frame member 110 includes a first set of elongated elements 112, and the second frame member 120 includes a second set of elongated elements 122. The frame components 110, 120 including, for example, the elongated elements 112, 122 may be discrete and separate from each other. For example, the first frame member 110 forms a first side 100a of the device 100, and the second frame member 120 forms a second side 100b of the device 100. The first frame member 110 that is discrete (discrete) and separate from the second frame member 120 does not enter the second side 100b of the device, and the second frame member 120 that is discrete (discrete) and separate from the first frame member 110 does not enter the first side 100a of the device.
[0057] In some cases, the first frame member 110 and the second frame member 120 are not adjacent to (not contiguous with) each other. The first frame member 110 and the second frame member 120 are not adjacent to (not contiguous with) each other so that the first frame member 110 and the second frame member 120 are distinct and separate from each other. In addition, the first frame member 110 and the second frame member 120 are free to move separately from (independently of) each other in response to the movement of the patient's anatomy. In this way, a force acting on one of the first frame member 110 and the second frame member 120 is maintained within the other of the first frame member 110 and the second frame member 120. A force acting on one of the first frame member 110 and the second frame member 120 can be isolated from the frame member on which the force acts.
[0058] As shown, the conduit portion 130 is disposed between the first frame member and the second frame member. At least a portion of the conduit portion 130 is not supported by the first frame member 110 and the second frame member 120 in a substantially radial or circumferential direction within the conduit portion 130. Figure 2 As shown, the conduit portion 130 transitions to the first side 100a and the second side 100b at an angle of approximately 90 degrees (other angles are also contemplated). The boundary of the conduit portion 130 can be considered to be the location where the conduit portion 130 transitions to the first side 100a and the second side 100b. The first frame member 110 and the second frame member 120 extend laterally relative to the conduit portion 130. In addition, the first frame member 110 and the second frame member 120 can support the conduit portion 130 without substantially entering the boundary of the conduit portion 130. In some cases, the first frame member 110 and the second frame member 120 support the conduit portion 130 laterally from outside the boundary of the conduit portion 130. Therefore, the first frame member 110 and the second frame member 120 can maintain a cavity through the conduit portion 130 and promote the expansion (deployment) of the conduit portion 130 by laterally forcing the conduit portion 130 to open.
[0059] In some cases, the first frame member 110 and the second frame member 120 can apply tension to the catheter portion 130 to expand and maintain the catheter portion 130 having a lumen therethrough. The catheter portion 130 can be expanded (deployed) within the septum between the tissue surfaces through an opening (e.g., a needle puncture through the septum) having a diameter that is smaller than the fully expanded diameter of the catheter portion 130. The tension in the catheter portion 130 applied by the expansion of the first frame member 110 and the second frame member 120 can also expand the septum between the tissue surfaces to a desired shunt size.
[0060] In some cases, the catheter portion 130 may be substantially free of frame components. For example, because the first frame component 110 and the second frame component 120 are not adjacent to each other as described above, and are disposed outside the boundary of the catheter portion 130. The catheter portion 130 may include, for example, a membrane 132 connecting the first frame component 110 and the second frame component 120, such as an expanded polytetrafluoroethylene (ePTFE) membrane. The membrane 132 generally separates the first frame component 110 and the second frame component 120 at a suitable distance compatible with the patient's body. For example, depending on the desired treatment position in the patient's body, the membrane 132 may separate the first frame component 110 and the second frame component 120 by a gap of 0 to 15 mm. In addition, the catheter portion may be formed only by the membrane 132. The catheter portion 130 is configured to be deployed within the septum between the tissue surfaces, and there is no first frame component 110 and second frame component 120. The catheter portion 130 may include a smooth interior that promotes blood flow therethrough without interruptions from the stent element or ridges that disrupt flow. Therefore, the catheter portion 130 can reduce the chance of thrombosis.
[0061] In addition to the membrane 132 forming the conduit portion 130, the membrane 132 may also cover at least a portion of the first frame member 110, at least a portion of the second frame member 120, or at least a portion of the first frame member 110 and the second frame member 120. In some cases, the membrane 132 disposed on at least a portion of the first frame member 110 and / or the second frame member 120 is a separate membrane film (e.g., a first membrane film disposed on the first frame member 110 and a second membrane film disposed on the second frame member 120). In these cases, one or more membrane films may be coupled to the membrane 132 in the conduit portion 130. The membrane 132 may be elastic to allow the conduit portion 130 to expand and to allow movement of portions of the first frame member 110 and / or the second frame member 12 (e.g., movement of the first group of elongated elements 112 and / or the second group of elongated elements 122).
[0062] The membrane 132 may span the gaps between the first group of elongated elements 112 and / or the second group of elongated elements 122. In some cases, the membrane 132 is disposed at least on the tissue engaging side of the first frame member 110 and on the tissue engaging side of the second frame member 120. In these cases, the membrane 132 is configured to reduce the possibility of frame corrosion of the first frame member 110 and / or the second frame member 120. The arrangement of the membrane 132 and the first group of elongated elements 112 and / or the second group of elongated elements 122 may conform to the tissue surface surrounding the diaphragm. The first group of elongated elements 112 and / or the second group of elongated elements 122 may lie flat on the tissue surface.
[0063] In some cases, each of the first set of elongated elements 112 can be attached to each other via the film 132 to form the first frame member 110. In some cases, the first frame member 110 can form a substantially flat (planar) or two-dimensional disk-like shape, as shown. Additionally or alternatively, the second set of elongated elements 122 can also be attached to each other via the film material 132 to form the second frame member 120. The second frame member 120 can also form a substantially flat (planar) or two-dimensional disk-like shape, such that when the device 100 is in the deployed configuration, the first frame member 110 and the second frame member 120 are substantially parallel to each other.
[0064] In some cases, the membrane 132 may be configured to promote tissue ingrowth at or on at least a portion of the membrane 132. In some cases, the membrane 132 is configured to promote tissue ingrowth to cover at least a portion of the first frame member 110 and / or the second frame member 120, which can further promote compatibility and stability of the device 100 in the patient's body. The membrane 132 within the catheter portion 130 may be configured to not allow tissue ingrowth, which results in increased patency. In some cases, the membrane 132 is configured to promote endothelialization without obstructive ingrowth within the catheter portion 130. The membrane 132 can promote endothelialization without obstructive overgrowth of tissue into the catheter portion 130.
[0065] In some cases, the device 100 may be capable of delivering a drug to a desired treatment location within a patient. For example, the device 100 may be capable of eluting a drug configured to modulate a tissue response. In some cases, the device 100 may be coated with a therapeutic coating, a drug eluting material, or other therapeutic material or hydrophilic coating. In one specific example, the device 100 may be coated with heparin to promote the anti-thrombotic and patency properties of the device 100. Alternatively or additionally, the device 100 may include paclitaxel (for modulating a tissue / cellular response).
[0066] Figure 3A1 is a perspective view of another example implantable medical device 100 for regulating blood pressure according to an embodiment. As shown, each of the first group of elongated elements 112 can be discrete and separate from adjacent elongated elements. In other words, the membrane 132 does not connect each of the first group of elongated elements 112 together. In this way, each of the first group of elongated elements 112 can move independently of each other and conform to the topology of the first side of the diaphragm individually, thereby providing a highly compliant first frame member 110. Each of the second group of elongated elements 122 can also be discrete and separate from adjacent elongated elements. For example, each of the second group of elongated elements 122 can move independently of each other and conform to the second side of the diaphragm individually, very similar to the first group of elongated elements 112 conforming to the first side of the diaphragm. Therefore, both the first frame member 110 and the second frame member 120 are highly compliant and can conform independently of each other based on the patient's anatomical structure.
[0067] In some cases, one of the first set of elongated elements 112 or the second set of elongated elements 122 of the first frame member 110 and the second frame member 120 can be attached to each other via the membrane 132, while the other set of elongated elements are unattached (e.g., they are discrete and separated from adjacent elongated elements). In other cases, only some of the first set of elongated elements 112 or the second set of elongated elements 122 can be attached to each other, while other elongated elements of the first set of elongated elements 112 and the second set of elongated elements 122 are unattached. Thus, the device 100 can be highly customizable to the patient depending on factors such as the desired treatment location in the patient's body and the size and / or shape of the defect.
[0068] The device 100 can generally be deployed or expanded from a delivery configuration to a deployed configuration. In some cases, the first set of elongated elements 112 and the second set of elongated elements 122 can be nested with each other when the device is in the delivery configuration. This allows the device 100 to be compressed to a smaller size, for example, for delivering the device 100 to a wider variety of treatment locations (e.g., through small, narrow or convoluted passages).
[0069] Figure 3B According to an embodiment, Figure 3A A side view of an implantable medical device for regulating blood pressure is shown in FIG. Figure 3BThe device 100 is shown in an expanded configuration. As shown, when the device 100 is in the expanded configuration, the first frame member 110 including the first group of elongated elements 112 and the second frame member 120 including the second group of elongated elements 122 are positioned radially outward relative to the longitudinal axis L of the catheter portion 130. For example, the first frame member 110 and the second frame member 120 are positioned at a first angle 114 and a second angle 124, respectively. When the device is in the expanded configuration, the first angle 114 and the second angle 124 can form an angle of about 90° relative to the longitudinal axis L. This allows the first frame member 110 and the second frame member 120 to be positioned parallel to and adjacent to the first and second sides of the septum. In some cases, the first frame member 110 and the second frame member 120 can be positioned at any angle relative to the longitudinal axis L (e.g., from about 0° to greater than 90° relative to the longitudinal axis L) that allows contact with tissue surfaces on the first and second sides of the septum.
[0070] In some cases, first elongated member 112 and second elongated member 122 are configured to separate from each other when device 100 is in the deployed configuration. Figure 3B As shown, when the device 100 is in the deployed configuration, each of the first group of elongated elements 112 is discrete and separated from each other, so that each of the first group of elongated elements 112 can move independently of adjacent elongated elements. When the device 100 is in the deployed configuration, each of the second group of elongated elements 122 can also be discrete and separated from each other, so that each of the second group of elongated elements 122 can move independently of adjacent elongated elements.
[0071] The first frame member 110 and the second frame member 120 can maintain a cavity through the catheter portion 130 and promote the expansion (deployment) of the catheter portion 130 by laterally forcing the catheter portion 130 to open. In addition, the cavity can be free or without the first frame member 110 and the second frame member 120. In this way, the catheter portion 130 can facilitate the re-passing of the septum for additional surgical procedures (e.g., left atrial appendage occluder implantation). In addition, the first frame member 110 and the second frame member 120 can be configured differently. For example, one of the first frame member 110 and the second frame member 120 can be expanded (outward), while the other of the first frame member 110 and the second frame member 120 is flat (planar). In other cases, both the first frame member 110 and the second frame member 120 can be expanded. Furthermore, one of the first frame member 110 and the second frame member 120 may be convex, while the other of the first frame member 110 and the second frame member 120 is flat or concave, or both of the first frame member 110 and the second frame member 120 may be convex. Additionally, one of the first frame member 110 and the second frame member 120 may be concave, while the other of the first frame member 110 and the second frame member 120 is flat or convex, or both of the first frame member 110 and the second frame member 120 may be concave. Furthermore, the first frame member 110 and the second frame member 120 may have different sizes.
[0072] The first frame member 110 and the second frame member 120 may include sensors integrated into the respective frame members, for example, for continuously monitoring various hemodynamic parameters in a patient, such as parameters such as pressure. For example, an antenna or inductor may be wrapped around the perimeter of one of the first frame member 110 and the second frame member 120, and the sensor may be attached to the inductor. The sensor may be configured to sense physiological characteristics that may be important in diagnosing, monitoring, and / or treating heart disease, heart failure, and / or other cardiovascular diseases, such as temperature, electrical signals of the heart, blood chemistry, blood pH, hemodynamics, biomarkers, sound, pressure, and electrolytes.
[0073] In some cases, the catheter portion 130 can be adjustable in size after delivery. The membrane 132 can be selectively adjusted by a balloon applied in the catheter portion 130 to expand the membrane 132. The device 100 can be any size suitable for the anatomical structure of the patient. In some cases, the diameter of the catheter portion is from 3 to 12 mm. For example, depending on the anatomical structure of the patient and / or the desired treatment position, the diameter of the catheter portion can be from 4 to 10 mm, or from 5 to 8 mm. For example, the diameter of the first frame member 110 and the second frame member 120 is generally larger than the diameter of the catheter portion 130, so that each frame member can anchor the catheter portion 130 of the device 100 in the septum.
[0074] The device 100 can have any shape suitable for matching the patient's anatomy. For example, the first frame portion 110 and the second frame portion 120 can have any of a variety of suitable shapes for anchoring the device 100 in the patient's body. For example, the first frame portion 110 and the second frame portion 120 can be generally circular, oval, diamond-shaped, star-shaped, flower-shaped, or any other suitable shape as desired. In some cases, for example, at least one of the first group of elongated elements 112 and the second group of elongated elements 122 forms a star shape. In some cases, both the first group of elongated elements 112 and the second group of elongated elements 122 form a star shape.
[0075] In some cases, the first group of elongated elements 112 forms a plurality of first lobes 116, while the second group of elongated elements 122 forms a plurality of second lobes 126. Each of the plurality of first lobes 116 and the second lobes 126 may include, for example, 3 to 12 lobes, 4 to 10 lobes, or 6 to 8 lobes as desired. In some cases, the plurality of first lobes 116 may have more lobes than the plurality of second lobes 126, while in other cases, the plurality of first lobes 116 may have the same number of lobes as the plurality of second lobes 126 or fewer lobes.
[0076] Figure 4 1 is another example implantable medical device 100 according to an embodiment. In some cases, the device 100 may include a cover 160 positioned on at least a portion of the catheter portion 130. The cover 160 may be formed, for example, of a graft material such as the material used for the membrane 132. The cover 160 is configured to reduce the amount of fluid passing through the catheter portion 130, or in some cases, is configured to completely prevent fluid from passing through the catheter portion 130. Thus, the cover 160 can partially or completely occlude the septum as desired. In these cases, the device 100 can be an occluder. When used as an occluder, the expanded catheter portion 130 can be centered at a target location (e.g., within a defect).
[0077] Figures 5A-5C A perspective view of another example implantable medical device for regulating blood pressure according to an embodiment is shown. As shown, the plurality of first convex corners 116 and second convex corners 126 of the first group of elongated elements 112 and the second group of elongated elements 122 can have a variety of shapes. For example, the shape of each convex piece in the first group of elongated elements 112 and the second group of elongated elements 122 can be generally elongated, triangular, (long) rhombus, or petal-shaped.
[0078] Figure 5A 1 is a first perspective view of another example implantable medical device for regulating blood pressure according to an embodiment. As shown, the first and second groups of elongated elements 112, 122 form the first and second frame portions 110, 120 of the device 100, and each of the first and second groups of elongated elements 112, 122 includes three lobes. As shown, the shape of the plurality of first lobes 116 and / or the plurality of second lobes 126 can be slightly elongated.
[0079] The device 100 can generally be deployed or expanded from a delivery configuration to a deployed configuration. In some cases, when the device is in the delivery configuration, the first group of elongated elements 112 and the second group of elongated elements 122 are nested with each other. This allows the device 100 to be compressed to a smaller size, for example, for delivering the device 100 to a wider variety of treatment locations (e.g., through small, narrow or convoluted passages).
[0080] like Figure 5B As shown, the first group of elongated elements 112 may have a substantially different shape than the second group of elongated elements 122. For example, the plurality of first lobes 116 are elongated in shape, while the plurality of second lobes 126 are triangular in shape. As shown, the first group of elongated elements 112 are attached to the first frame member 110, while the second group of elongated elements 122 are attached to the second frame member 120. Both the first frame member 110 and the second frame member 120 may extend into the conduit portion 130. However, neither the first frame member 110 nor the second frame member 120 extends into the opposing frame member (e.g., the first frame member 110 does not extend into the second side 100b, and the second frame member 120 does not extend into the first side 100a). In some cases, a bracket or frame element disposed within the conduit portion 130 may be formed by a third frame member, such as with reference to FIG. Fig.10 The first frame member 110 and the second frame member 120 may be maintained through the lumen of the catheter portion 130 and facilitate expansion (deployment) of the catheter portion 130 by laterally forcing the catheter portion 130 to open. Figure 5C1 is a third stereoscopic view of an implantable medical device for regulating blood pressure according to an embodiment. As shown, in some cases, the first group of elongated elements 112 may include a first plurality of support struts 118, and the second group of elongated elements 122 may include a second plurality of support struts 128. The first plurality of support struts 118 and the second plurality of support struts 128 typically form a support structure within each elongated element, which can increase the strength and / or stability of each elongated element. In some cases, the support struts 118, 128 can help deliver the device 100. For example, the support structure can provide a location where a delivery device can be easily attached to the device 100 when the device 100 is in a delivery configuration.
[0081] Figure 6 300 is an example stent pattern of an implantable medical device for regulating blood pressure according to an embodiment. In some cases, stent pattern 300 can be used in the process of producing device 100. For example, in some cases, device 100 is made of a tube or sheet of material, such as nitinol (NiTi) or stainless steel, which is cut according to stent pattern 300 and then expanded into device 100 such as Figure 2 -The construction shown in 5.
[0082] Figure 7 400 is another example of an implantable medical device for regulating blood pressure according to an embodiment. As described above, stent pattern 400 may be used in the process of producing device 100. For example, in some cases, device 100 is made of a tube or sheet of material, such as nitinol (NiTi) or stainless steel, which is cut according to stent pattern 300 and then expanded into device 100 such as Figure 2 -5. In other cases, each stent component may be formed from wire that is wrapped around a fixture and then heat set.
[0083] Figure 6 and Figure 7 The device 100 shown can generally be deployed or expanded from a delivery configuration to a deployed configuration. In some cases, when the device is in the delivery configuration, the first group of elongated elements 112 (not shown) and the second group of elongated elements 122 (not shown) can be nested with each other. This allows the device 100 to be compressed to a smaller size, for example, for delivering the device 100 to a wider variety of treatment locations (e.g., through small, narrow or convoluted passages).
[0084] In some cases, the device 100 as discussed herein may include multiple frame components. The frame components may be formed by separate (material) tubes or material sheets, or by a single (material) tube or material sheet. In other cases, each frame component may be formed separately by one or more wires, or each frame component may be formed together by one or more wires. As discussed herein, multiple elongated elements may be parts of struts, wires, or (multiple materials) tubes or (multiple) material sheets that form part of each frame component.
[0085] Figure 8A-8D An implantable medical device 100 is shown according to an embodiment. Fig. 8A and Figure 8B The device 100 is shown disposed on a mandrel. As shown, the device 100 includes opposing first and second frame portions 110, 120 having a first series of elongated elements 112 and a second series of elongated elements 122 positioned radially outward from a conduit portion 130, such as Figure 2 , Figure 3A and 3B Each of the first series of elongated elements 112 and the second series of elongated elements 122 may include eyelets configured to facilitate delivery of the device 100. For example, the first series of elongated elements 112 includes a first plurality of eyelets 190 and the second series of elongated elements 122 includes a second plurality of eyelets 192. Figure 8C and 8D Shows Fig. 8A and Figure 8B The device 100 is shown implanted in a patient at a desired treatment location. The eyelets 190, 192 may interface with a wire or suture-like element on a delivery system to constrain portions of the implantable medical device 100 and, in some cases, to constrain the recaptureability of the device 100.
[0086] Fig. 91 is another example implantable medical device 100 according to an embodiment. As shown, the first frame portion 110 may include a first protrusion 196 extending outwardly from the surface of the first frame portion 110 along the longitudinal axis. The second frame portion 120 may also include a second protrusion 198 extending outwardly from the surface of the second frame portion 120 along the longitudinal axis. The first protrusion 196 and the second protrusion 198 may be formed by, for example, a stent frame. The first protrusion 196 and the second protrusion 198 may be independent of the first frame portion 110 and the second frame portion 120. The protrusions 196, 198 may intersect the first frame portion 110 and the second frame portion 120 at 90 degrees (for example, as shown) or at an angle greater than or less than 90 degrees, such as 30 degrees, 35 degrees, 40 degrees, 45 degrees, 50 degrees, 55 degrees, 60 degrees, 65 degrees, 70 degrees, 75 degrees, 80 degrees, 85 degrees, or any angle therebetween. The first and second protruding portions 196, 198 may be size adjustable after the device 100 is delivered into the body or to a patient.
[0087] In some cases, a method for regulating blood pressure includes delivering the device 100 to a desired treatment position in a patient's body when the device 100 is in a delivery configuration. The device 100 can then be positioned so that the catheter portion 130, for example, spans the septum between the left atrium and the right atrium of the heart, or any other defect in the patient's body as required. The device 100 is then expanded from the delivery configuration to the deployment configuration so that the first frame member 110 and the second frame member 120 extend radially outward from the catheter portion 130, so that the catheter portion 130 opens a desired amount to provide a fluid flow path through the device 100 (for example, in some cases, between the left atrium and the right atrium). In some cases, the tension on the device 100 can be adjusted to further adjust the diameter of the catheter portion 130 of the device 100. This can, for example, adjust the fluid flow rate through the device 100 and allow more or less fluid to pass through the catheter portion 130 of the device 100 as required.
[0088] Fig.10 1 is another example implantable medical device according to one embodiment. Device 100 may be used to regulate blood pressure according to one embodiment. As shown, device 100 may include a first frame portion 110 and a second frame portion 112. As described in more detail below, device 100 includes a third frame portion 150, which may be configured to expand catheter portion 130 by self-expansion or balloon expansion. Fig.10As shown, the first frame member 110 of the device 100 can be disposed on a first side of the diaphragm, and the second frame member 120 can be disposed on a second side of the diaphragm. Each of the frame portions 110, 120 and the conduit portion 130 can include a membrane 132. The membrane 132 can cover at least a portion of the first frame member 110, at least a portion of the second frame member 120, or at least a portion of the first frame member 110 and the second frame member 120. The membrane 132 can be elastic to allow the conduit portion 130 to expand and allow portions of the first frame member 110 and / or the second frame member 120 to move.
[0089] In some cases, the first set of elongated elements 112 and the second set of elongated elements 122 (eg, struts, wires, frame elements, stent elements) form the first frame portion 110 and the second frame portion 120 of the device 100. Fig.10 As shown, the first set of elongated elements 112 form the first frame member 110, and the second set of elongated elements 122 form the second frame member 120. Both the first frame member 110 and the second frame member 120 can extend into the conduit portion 130. In some embodiments, neither the first frame member 110 nor the second frame member 120 extends into the opposing frame member (e.g., the first frame member 110 does not extend into the second side 100b, and the second frame member 120 does not extend into the first side 100a).
[0090] Additionally, a third frame component 150 (e.g., a bracket or frame element) can be disposed within the conduit portion 130. The third frame component 150 can be in addition to the first frame component 110 and / or the second frame components 110, 120 extending into the conduit portion 130, or the third frame component 150 can be the only frame or bracket component within the conduit portion 130. The third frame component 150 can be disconnected or unconnected from either the first frame component 110 or the second frame component 120.
[0091] In some cases, the catheter portion 130 can be size-adjustable after delivery. In some cases, the third frame member 150 is balloon expandable. After implantation, the catheter portion 130 can be size-adjustable with the third frame member 150 configured to expand. The catheter portion 130 can be sized (adjusted) to a desired diameter by a balloon. In some cases, the third frame member 150 can be configured to self-expand. In addition, the third frame member 150 can be configured to expand the catheter portion 130 and, in some cases, expand the surrounding tissue.
[0092] In some cases, first frame member 110 and second frame member 120 are self-expanding. First frame member 110 and second frame member 120 can be configured to conform to tissue on either side of the septum. In some cases, first set of elongated elements 112 can move independently of one another and conform independently to the topology of a first side of the septum, and second set of elongated elements 122 can move independently of one another and conform independently to the topology of a second side of the septum. Thus, first frame member 110 and second frame member 120 can both be highly conformable and can conform independently of one another based on the patient's anatomy.
[0093] The device 100 discussed herein may be removable. In some cases, if treatment is no longer effective or is no longer needed, the device 100 may be replaced or removed. As described above, the device 100 may be coated with a drug such as paclitaxel to deliver the drug to a target anatomical location. In some cases, the use of certain drugs may prevent the healing of a dilated septal puncture, resulting in the formation of an atrial shunt. The device 100 may be used as a pressure relief valve to allow blood pressure to flow from the left atrium to the right atrium, reducing the workload on the heart.
[0094] Examples of synthetic polymers suitable for use as membrane materials (which can be used as membrane components) include, but are not limited to, nylon, polyacrylamide, polycarbonate, polyoxymethylene, polymethyl methacrylate, polytetrafluoroethylene, polychlorotrifluoroethylene, polyvinyl chloride, polyurethane, elastomeric silicone polymers, polyethylene, polypropylene, polyurethane, polyglycolic acids, polyesters, polyamides, and mixtures, blends, and copolymers thereof. In one embodiment, the membrane is made of (a class of) polyesters, polyfluorocarbons, and porous or non-porous polyurethanes, such as polyethylene terephthalate, including and , and polyaramids, such as , and the above-mentioned polyfluorocarbons such as hexafluoropropylene ( or ) of polytetrafluoroethylene (PTFE). In some cases, the membrane includes expanded fluorocarbon polymers (particularly PTFE) materials described in British Patent Nos. 1,355,373, 1,506,432 or 1,506,432 or in U.S. Patent Nos. 3,953,566, 4,187,390 or 5,276,276, which are incorporated herein by reference in their entirety. Included in this class of preferred fluoropolymers are polytetrafluoroethylene (PTFE), fluorinated ethylene propylene (FEP), copolymers of tetrafluoroethylene (TFE) and perfluoro(propyl vinyl ether) (PFA), homopolymers of polytrifluorochloroethylene (PCTFE), and copolymers thereof with TFE, ethylene-chlorotrifluoroethylene (ECTFE), copolymers of ethylene-tetrafluoroethylene (ETFE), polyvinylidene fluoride (PVDF) and polyvinyl fluoride (PVF). ePTFE is particularly preferred due to its widespread use in vascular prostheses. In some embodiments, the membrane includes a combination of the materials listed above. In some cases, the membrane is substantially impermeable to body fluids. The substantially impermeable membrane can be made of a material that is substantially impermeable to body fluids, or can be constructed of a permeable material that is treated or manufactured (e.g., by laminating different types of materials as described above or known in the art) to be substantially impermeable to body fluids.
[0095] Other examples of membrane materials include, but are not limited to, vinylidene fluoride / hexafluoropropylene hexafluoropropylene (HFP), tetrafluoroethylene (TFE), vinylidene fluoride, 1-hydropentafluoropropylene, perfluoro(methyl vinyl ether), chlorotrifluoroethylene (CTFE), pentafluoropropylene, trifluoroethylene, hexafluoroacetone, hexafluoroisobutylene, fluorinated poly(ethylene-co-propylene) (FPEP), poly(hexafluoropropylene) (PHFP), poly(chlorotrifluoroethylene) (PCTFE), poly(vinylidene fluoride) (PVDF), poly(vinylidene fluoride-co-tetrafluoroethylene) (PVDF-TFE), poly(vinylidene fluoride-co-hexafluoropropylene) (PVDF-HFP), poly(tetrafluoroethylene-co-hexafluoropropylene) Poly(PTFE-HFP), poly(tetrafluoroethylene-co-vinyl alcohol) (PTFE-VAL), poly(tetrafluoroethylene-co-vinyl acetate) (PTFE-VAC), poly(tetrafluoroethylene-co-propylene) (PTFEP), poly(hexafluoropropylene-co-vinyl alcohol) (PHFP-VAL), poly(ethylene-co-tetrafluoroethylene) (PETFE), poly(ethylene-co-hexafluoropropylene) (PEHFP), poly(vinylidene fluoride-co-chlorotrifluoroethylene-ethylene) (PVDF-CTFE), and combinations thereof, and other polymers and copolymers described in U.S. Publication No. 2004 / 0063805, the entire contents of which are incorporated herein by reference for all purposes. Other polyfluoropolymers include tetrafluoroethylene (TFE) / perfluoroalkyl vinyl ether (PAVE). The PAVE may be perfluoromethyl vinyl ether (PMVE), perfluoroethyl vinyl ether (PEVE), or perfluoropropyl vinyl ether (PPVE), as substantially described in U.S. Publication No. 2006 / 0198866 and U.S. Pat. No. 7,049,380, both of which are incorporated herein by reference in their entirety for all purposes. Other polymers and copolymers include: polylactides, polycaprolactone-glycolides, polyorthoesters, polyanhydrides; polyamino acids; polysaccharides; polyphosphazenes; poly(ether-ester) copolymers such as PEO-PLLA or blends thereof, polydimethylsiloxanes; poly(ethylene-vinyl acetate); acrylate-based polymers or copolymers such as poly(hydroxyethyl methyl methacrylate), polyvinyl pyrrolidone; fluorinated polymers such as polytetrafluoroethylene; cellulose esters, and any of the polymers and copolymers described in U.S. Publication No. 2004 / 0063805, the entirety of which is incorporated herein by reference.
[0096] As discussed herein, the membrane component can be attached to the self-expanding frame component by using a coupling member, which is generally a flat (flat) belt or belt having at least one substantially flat surface. In some cases, the belt member is made of expanded PTFE (ePTFE) coated with an adhesive. The adhesive can be a thermoplastic adhesive. In some cases, the thermoplastic adhesive can be fluorinated ethylene propylene (FEP). More specifically, the FEP-coated side of the ePTFE can face and contact the outer surfaces of the self-expanding frame component and the membrane component, thereby attaching the self-expanding frame component to the membrane component. The materials and methods for attaching the frame component to the membrane are discussed in U.S. Patent No. 6,042,602 to Martin, which is incorporated herein by reference for all purposes.
[0097] The frame components discussed herein can be made of various biocompatible materials. These materials can include 316L stainless steel, cobalt-chromium-nickel-molybdenum-iron alloy ("cobalt-chromium"), other cobalt alloys such as L605, tantalum, nickel-titanium alloys (e.g., nitinol) or other biocompatible metals. In some cases, as discussed in detail above, the frame components (and membranes) can be self-expanding. The prosthesis can be balloon (capsule) expandable. In other cases, the frame components can be made of polymers (e.g., polyetheretherketone (Peek)) and / or bioabsorbable materials (e.g., polylactic acid-acetic acid alcohol (PLGA), polyglycolic acid: propylene carbonate (PGA-TMC)).
[0098] Various materials of various metals, such as superelastic alloys of Nitinol, are suitable for these frame components. The main requirement for the materials is that they are reasonably elastic even when made into very thin sheets or small diameter wires. Various stainless steels that have been physically, chemically, and otherwise treated to produce high elasticity are suitable for use with superelastic alloys such as cobalt-chromium alloys (e.g., Other metal alloys such as ), platinum / tungsten alloys, and especially nickel-titanium alloys (eg, Nitinol) are also suitable.
[0099] The invention of the present application has been described above generally and with reference to specific embodiments. It will be apparent to those skilled in the art that various modifications and changes may be made to the embodiments without departing from the scope of the present disclosure. Therefore, the embodiments are intended to cover modifications and changes of the present invention as long as they fall within the scope of the appended claims and their equivalents.
Claims
1. An implantable medical device comprising: a first frame member configured to conform to the patient's anatomy; a second frame member configured to conform to the anatomy of the patient, wherein the first frame member and the second frame member are discrete and separate from one another; and A conduit portion disposed between the first frame member and the second frame member, the conduit portion comprising a membrane connecting the first frame member and the second frame member, wherein the membrane generally separates the first frame member and the second frame member by a suitable distance compatible with the patient's body, wherein the conduit portion is free of the first frame member and the second frame member and is formed only by the membrane.
2. The device according to claim 1, characterized in that At least a portion of the conduit portion is not radially supported by the first frame member and the second frame member.
3. The device according to claim 2, characterized in that The first frame member and the second frame member are configured to facilitate deployment of the catheter portion and maintain a lumen through the catheter portion.
4. The device according to claim 1 or 2, characterized in that The first frame member includes a first set of elongated elements and the second frame member includes a second set of elongated elements, and the first set of elongated elements and the second set of elongated elements are not adjacent to each other.
5. The device according to claim 4, characterized in that The first group of elongated elements comprises a first plurality of support struts, and wherein the second group of elongated elements comprises a second plurality of support struts, the first plurality of support struts and the second plurality of support struts forming a support structure within each elongated element.
6. The device according to claim 5, characterized in that The first set of elongated elements forms a first plurality of lobes.
7. The device according to claim 5, characterized in that The first set of elongated elements forms a star shape.
8. The device according to claim 4, characterized in that The first frame member forms a first side and the second frame member forms a second side, and wherein at least one elongated element of the first group of elongated elements is disposed within the first frame member without penetrating the second side, and wherein the second group of elongated elements is disposed within the second frame member without penetrating the first side.
9. The device according to claim 8, characterized in that At least one of the first and second sets of elongated elements extends within the catheter portion.
10. The device according to claim 1 or 2, characterized in that The membrane extends to at least partially cover portions of one or both of the first frame member and the second frame member.
11. The device according to claim 10, characterized in that The membrane is configured to promote tissue ingrowth to cover at least a portion of one or both of the first frame member and the second frame member.
12. The device according to claim 1 or 2, characterized in that Also included is a first membrane disposed on the first frame component and a second membrane disposed on the second frame component.
13. The device according to claim 1 or 2, characterized in that The film separates the first frame member and the second frame member by a gap of 0 to 15 mm.
14. The device according to claim 1 or 2, characterized in that: The conduit portion is formed only from the membrane.
15. The device according to claim 1 or 2, characterized in that: The first frame member and the second frame member are positioned radially outward relative to a longitudinal axis of the catheter portion when the device is in a deployed configuration, wherein the first frame member and the second frame member are positioned at a first angle and a second angle, respectively.
16. The device according to claim 1 or 2, characterized in that: The membrane is elastic to allow partial expansion of the conduit and to allow partial movement of the first frame member and / or the second frame member.
17. The device according to claim 1 or 2, characterized in that: The first frame member defines a first side of the device and the second frame member defines a second side of the device, wherein the conduit portion is not supported by the first frame member and the second frame member in a substantially radial or circumferential direction within the conduit portion, and the conduit portion transitions to the first side and the second side at approximately a 90 degree angle.
18. An implantable medical device for regulating blood pressure between the left atrium and the right atrium of a heart, the device comprising: a catheter portion configured to span the septum of the heart and configured to allow fluid to flow therethrough; as well as A frame component comprising a first group of elongated elements disposed on a first side of the catheter portion and a second group of elongated elements disposed on a second side of the catheter portion, wherein the first group of elongated elements and the second group of elongated elements are not adjacent to each other, wherein the catheter portion generally separates the first group of elongated elements and the second group of elongated elements by a suitable distance compatible with the patient's body, and the catheter portion is free of the frame component, wherein the catheter portion is formed only by a membrane.
19. The device according to claim 18, characterized in that The frame member forms a first side including the first group of elongated elements and a second side including the second group of elongated elements, and wherein the first group of elongated elements are disposed within the first side and the conduit portion and the second group of elongated elements are disposed within the second side and the conduit portion.
20. The device according to claim 18 or 19, characterized in that The first and second groups of elongated members extend radially outward from the conduit portion to form a first and second angle, and wherein the first and second angles are approximately 90° angles relative to the conduit portion.
21. The device according to claim 18 or 19, characterized in that Also included is a sensor disposed with the catheter portion or the frame member, and the sensor is configured to sense at least one of a physiological property, hemodynamics, a biomarker, sound, pressure, and electrolytes.
22. The device according to claim 18 or 19, characterized in that Also included is at least one of a heparin coating for promoting anti-thrombotic properties and patency of the device and a paclitaxel coating for modulating tissue / cellular responses.
23. An implantable medical device comprising: a first frame member; a second frame member, wherein the first frame member and the second frame member are discrete and separate from one another; and A catheter portion disposed between the first frame member and the second frame member, the catheter portion including a membrane connecting the first frame member and the second frame member, the membrane being configured to expand in response to tension applied in the catheter portion by expansion of the first frame member and the second frame member, wherein the membrane generally separates the first frame member and the second frame member by a suitable distance compatible with the patient's body, wherein the catheter portion is free of the first frame member and the second frame member and is formed only by the membrane.
24. The device according to claim 23, characterized in that The catheter portion is configured to span a septum between a left atrium and a right atrium of a patient, and the catheter portion is configured to expand the septum in response to tension applied in the catheter portion by expansion of the first frame member and the second frame member.
25. The device according to claim 24, characterized in that The catheter portion is configured to maintain an expanded diameter of the septum.
26. The device according to claim 23, characterized in that The first frame part forms a first side and the second frame part forms a second side, and wherein at least one of the first set of elongated elements is disposed within the first frame part without penetrating the second side and the second set of elongated elements is disposed within the second frame part without penetrating the first side.
27. The device according to claim 26, characterized in that At least one of the first and second sets of elongated elements extends within the catheter portion.
